| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-05-29 13:24:44 -0600 |
| HMDB ID |
HMDB00089 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Cytidine |
| Description |
Cytidine is a nucleoside that is composed of the base cytosine linked to the five-carbon sugar D-ribose. Cytidine is a pyrimidine that besides being incorporated into nucleic acids, can serve as substrate for the salvage pathway of pyrimidine nucleotide synthesis; as precursor of the cytidine triphosphate (CTP) needed in the phosphatidylcholine (PC) and phosphatidylethanolamine (PE) biosynthetic pathway. These variations probably reflect the species differences in cytidine deaminase, the enzyme that converts cytidine to uridine in the body. The transports of cytidine into the brain's extracellular fluid, and then into neurons and glia, are essential prerequisites for cytidine to be utilized in brain. An efficient mechanism mediating the brain uptake of circulating cytidine has not yet been demonstrated. The biosynthesis of PC, the most abundant phosphatide in the brain, via the Kennedy pathway requires phosphocholine and cytidine triphosphate (CTP), a cytidine nucleotide, which is involved in the rate-limiting step. The enzyme that converts CTP to endogenous CDP-choline (CTP: phosphocholine cytidylyltransferase) is unsaturated at physiological brain CTP levels. APOBEC is a family of enzymes has been discovered with the ability to deaminate cytidines on RNA or DNA. The human apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G (APOBEC3G, or hA3G) protein, provides cells with an intracellular antiretroviral activity that is associated with the hypermutation of viral DNA through cytidine deamination. Indeed, hA3G belongs to a family of vertebrate proteins that contain one or two copies of a signature sequence motif unique to cytidine deaminases (CTDAs). (PMID: 16769123 , 15780864 , 16720547 ). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- 1-(b-D-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine
- 1-(b-delta-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine
- 1-b-D-Ribofuranosylcytosine
- 1-b-D-Ribosyl-Cytosine
- 1-beta-D-Ribofuranosyl-Cytosine
- 1-beta-D-Ribofuranosylcytosine
- 1-beta-delta-Ribofuranosyl-Cytosine
- 1-beta-delta-Ribofuranosylcytosine
- 1-beta-delta-Ribosyl-Cytosine
- 1beta-D-Ribofuranosylcytosine
- 1beta-delta-Ribofuranosylcytosine
- 1beta-Ribofuranosylcytosine
- 4-Amino-1-b-D-ribofuranosyl-2(1H)-pyrimidinone
- 4-Amino-1-beta-delta-ribofuranosyl-2(1H)-pyrimidinone
- Cytidine
- Cytosine riboside
- Cytosine-1b-D-Ribofuranoside
- Cytosine-1b-delta-Ribofuranoside
- Cytosine-1beta-D-Ribofuranoside
- Cytosine-1beta-delta-Ribofuranoside
|
| Chemical Formula |
C9H13N3O5 |
| Average Molecular Weight |
243.2166 |
| Monoisotopic Molecular Weight |
243.085520541 |
| IUPAC Name |
4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one |
| Traditional IUPAC Name |
cytidine |
| CAS Registry Number |
65-46-3 |
| SMILES |
NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O |
| InChI Identifier |
InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m1/s1 |
| InChI Key |
UHDGCWIWMRVCDJ-XVFCMESISA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Nucleosides, Nucleotides, and Analogues |
| Class |
Pyrimidine Nucleosides and Analogues |
| Sub Class |
N/A |
| Other Descriptors |
- Aromatic Heteropolycyclic Compounds
- a pyrimidine ribonucleoside(Cyc)
|
| Substituents |
- 1,2 Diol
- Aminopyrimidine
- Glycosyl Compound
- Hydropyrimidine
- N Glycosyl Compound
- Oxolane
- Pentose Monosaccharide
- Primary Alcohol
- Pyrimidine
- Pyrimidone
- Saccharide
- Secondary Alcohol
|
| Direct Parent |
Pyrimidine Nucleosides and Analogues |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Pyrimidine metabolism
- Protein component
|
| Application |
Not Available
|
| Cellular locations |
- Extracellular
- Mitochondria
- Nucleus
- Lysosome
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
230.5 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
-2.51 |
HANSCH,C ET AL. (1995) |
|
| Predicted Properties |
|
| Spectra |
|
| 1H NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| MS/MS Spectrum LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) |
| [1H,1H] 2D NMR Spectrum |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
- Extracellular
- Mitochondria
- Nucleus
- Lysosome
|
| Biofluid Locations |
- Blood
- Cerebrospinal Fluid (CSF)
- Urine
|
| Tissue Location |
|
| Pathways |
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.25 +/- 0.19 uM |
Adult (>18 years old) |
Both |
Normal
|
|
| Blood |
Detected and Quantified |
|
0.1 +/- 0.0 uM |
Adult (>18 years old) |
Both |
Normal
|
|
| Cerebrospinal Fluid (CSF) |
Detected and Quantified |
|
0.44 +/- 0.32 uM |
Infant (0-1 year old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.78 (0.00-1.6) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.07 +/- 0.05 umol/mmol creatinine |
Adult (>18 years old) |
Female |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.08 +/- 0.06 umol/mmol creatinine |
Adult (>18 years old) |
Male |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.07 +/- 0.05 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
1.50 +/- 1.34 umol/mmol creatinine |
Children (1-13 year old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
1.12 +/- 0.69 umol/mmol creatinine |
Adolescent (13-18 years old) |
Both |
Normal
|
|
| Urine |
Detected and Quantified |
|
0.33 +/- 0.17 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal
|
|
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
0.26 +/- 0.13 uM |
Adult (>18 years old) |
Both |
Canavan disease
|
|
| Urine |
Detected and Quantified |
|
4.03 +/- 1.77 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Canavan disease
|
|
|
| Associated Disorders and Diseases |
| Disease References |
| Canavan disease |
- Tavazzi B, Lazzarino G, Leone P, Amorini AM, Bellia F, Janson CG, Di Pietro V, Ceccarelli L, Donzelli S, Francis JS, Giardina B: Simultaneous high performance liquid chromatographic separation of purines, pyrimidines, N-acetylated amino acids, and dicarboxylic acids for the chemical diagnosis of inborn errors of metabolism. Clin Biochem. 2005 Nov;38(11):997-1008. Epub 2005 Sep 1.
Pubmed: 16139832
|
|
| Associated OMIM IDs |
|
| External Links |
| DrugBank ID |
Not Available |
| DrugBank Metabolite ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB021809 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
5940  |
| KEGG Compound ID |
C00475  |
| BioCyc ID |
CYTIDINE  |
| BiGG ID |
35089  |
| Wikipedia Link |
Cytidine  |
| NuGOwiki Link |
HMDB00089  |
| Metagene Link |
HMDB00089  |
| METLIN ID |
3376  |
| PubChem Compound |
6175  |
| PDB ID |
CTN  |
| ChEBI ID |
17562  |
| References |
| Synthesis Reference |
Qu, Guirong; Yang, Xining; Shen, Yanhong; Dong, Chunhong; Guo, Haiming; Wang, Xiuqiang; Wang, Dongchao. Synthesis of cytidine. Faming Zhuanli Shenqing Gongkai Shuomingshu (2007), 11pp. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Lee SH, Jung BH, Kim SY, Chung BC: A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection. Rapid Commun Mass Spectrom. 2004;18(9):973-7.
Pubmed: 15116424
- Mahieux R, Suspene R, Delebecque F, Henry M, Schwartz O, Wain-Hobson S, Vartanian JP: Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases. J Gen Virol. 2005 Sep;86(Pt 9):2489-94.
Pubmed: 16099907
- Eells JT, Spector R: Purine and pyrimidine base and nucleoside concentrations in human cerebrospinal fluid and plasma. Neurochem Res. 1983 Nov;8(11):1451-7.
Pubmed: 6656991
- Schrofelbauer B, Yu Q, Zeitlin SG, Landau NR: Human immunodeficiency virus type 1 Vpr induces the degradation of the UNG and SMUG uracil-DNA glycosylases. J Virol. 2005 Sep;79(17):10978-87.
Pubmed: 16103149
- Min IM, Selsing E: Antibody class switch recombination: roles for switch sequences and mismatch repair proteins. Adv Immunol. 2005;87:297-328.
Pubmed: 16102577
- Zhong SQ, Sun LJ, Yan YZ, Sun YQ, Zhong YY: Effect of Xuesaitong soft capsule on hemorrheology and in auxiliarily treating patients with acute cerebral infarction. Chin J Integr Med. 2005 Jun;11(2):128-31.
Pubmed: 16150200
- Barbour JD, Grant RM: The role of viral fitness in HIV pathogenesis. Curr HIV/AIDS Rep. 2005 Feb;2(1):29-34.
Pubmed: 16091246
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4.
Pubmed: 19212411
- Cansev M: Uridine and cytidine in the brain: their transport and utilization. Brain Res Rev. 2006 Sep;52(2):389-97.
Pubmed: 16769123
- Huthoff H, Malim MH: Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins. Virology. 2005 Apr 10;334(2):147-53.
Pubmed: 15780864
- Navaratnam N, Sarwar R: An overview of cytidine deaminases. Int J Hematol. 2006 Apr;83(3):195-200.
Pubmed: 16720547
|
| Enzymes |
|
|
|
|
|
|
|
|
|
|
| Name: |
Uridine-cytidine kinase 1
|
| Reactions: |
| Adenosine triphosphate + Cytidine unknown ADP + Cytidine monophosphate |
details |
| Uridine triphosphate + Cytidine unknown Uridine 5'-diphosphate + Cytidine monophosphate |
details |
| Guanosine triphosphate + Cytidine unknown Guanosine diphosphate + Cytidine monophosphate |
details |
| Inosine triphosphate + Cytidine unknown IDP + Cytidine monophosphate |
details |
| Deoxyadenosine triphosphate + Cytidine unknown dADP + Cytidine monophosphate |
details |
| dGTP + Cytidine unknown dGDP + Cytidine monophosphate |
details |
| Thymidine 5'-triphosphate + Cytidine unknown dTDP + Cytidine monophosphate |
details |
| dCTP + Cytidine unknown dCDP + Cytidine monophosphate |
details |
| Deoxyuridine triphosphate + Cytidine unknown dUDP + Cytidine monophosphate |
details |
|
| Gene Name: |
UCK1 |
| Uniprot ID: |
Q9HA47  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
| Name: |
Uridine-cytidine kinase 2
|
| Reactions: |
| Adenosine triphosphate + Cytidine unknown ADP + Cytidine monophosphate |
details |
| Uridine triphosphate + Cytidine unknown Uridine 5'-diphosphate + Cytidine monophosphate |
details |
| Guanosine triphosphate + Cytidine unknown Guanosine diphosphate + Cytidine monophosphate |
details |
| Inosine triphosphate + Cytidine unknown IDP + Cytidine monophosphate |
details |
| Deoxyadenosine triphosphate + Cytidine unknown dADP + Cytidine monophosphate |
details |
| dGTP + Cytidine unknown dGDP + Cytidine monophosphate |
details |
| Thymidine 5'-triphosphate + Cytidine unknown dTDP + Cytidine monophosphate |
details |
| dCTP + Cytidine unknown dCDP + Cytidine monophosphate |
details |
| Deoxyuridine triphosphate + Cytidine unknown dUDP + Cytidine monophosphate |
details |
|
| Gene Name: |
UCK2 |
| Uniprot ID: |
Q9BZX2  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
| Name: |
AID
|
| Reactions: |
Not Available
|
| Gene Name: |
AID |
| Uniprot ID: |
Q546Y9  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
| Name: |
Uridine-cytidine kinase-like 1
|
| Reactions: |
| Adenosine triphosphate + Cytidine unknown ADP + Cytidine monophosphate |
details |
| Uridine triphosphate + Cytidine unknown Uridine 5'-diphosphate + Cytidine monophosphate |
details |
| Guanosine triphosphate + Cytidine unknown Guanosine diphosphate + Cytidine monophosphate |
details |
| Inosine triphosphate + Cytidine unknown IDP + Cytidine monophosphate |
details |
| Deoxyadenosine triphosphate + Cytidine unknown dADP + Cytidine monophosphate |
details |
| dGTP + Cytidine unknown dGDP + Cytidine monophosphate |
details |
| Thymidine 5'-triphosphate + Cytidine unknown dTDP + Cytidine monophosphate |
details |
| dCTP + Cytidine unknown dCDP + Cytidine monophosphate |
details |
| Deoxyuridine triphosphate + Cytidine unknown dUDP + Cytidine monophosphate |
details |
|
| Gene Name: |
UCKL1 |
| Uniprot ID: |
Q9NWZ5  |
| Protein Sequence: |
FASTA |
| Gene Sequence: |
FASTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|